학술논문

Elevated levels of anti- Chlamydia pneumoniae IgA and IgG antibodies in young adults with ischemic stroke.
Document Type
Article
Source
Acta Neurologica Scandinavica. Sep2007, Vol. 116 Issue 3, p144-149. 6p. 2 Charts, 1 Graph.
Subject
*CHLAMYDOPHILA pneumoniae
*CHLAMYDIA infections
*ENZYME-linked immunosorbent assay
*CEREBROVASCULAR disease patients
*RISK management in business
*ISCHEMIA
Language
ISSN
0001-6314
Abstract
Introduction – Data on the role of Chlamydia pneumoniae in patients with ischemic stroke are inconsistent. We investigated the presence of anti- C. pneumoniae antibodies in young adults with ischemic stroke. Methods – 94 patients (<55 years) with ischemic stroke and 103 controls were enrolled. Indices of anti- C. pneumoniae IgA and IgG were assessed with an ELISA. We determined OR and 95% CI for the IgA and IgG seropositivity in stroke cases. Results – Mean IgA and IgG indices were higher in stroke patients vs controls (IgA: 1.40 vs 0.56; P < 0.001; IgG: 0.85 vs. 0.78; P < 0.003). The IgA seropositivity was associated with stroke risk (11.92; 5.94–23.92; P < 0.001) as well as IgG seropositivity was (2.31; 1.15–4.61; P < 0.016). Seropositivity assessed with combined IgA and IgG indices was associated with increased stroke risk (OR 9.35; 95% CI 4.78–18.29; P < 0.0001). After controlling for age and sex, the IgA seropositivity yielded a significantly adjusted OR for stroke (8.95; 4.44–18.07; P < 0.002), while IgG seropositivity did not (0.85; 0.53–1.63). Conclusions – We find an increased risk of stroke in young patients seropositive to C. pneumoniae in the IgA antibody class. Further studies to explore this finding are warranted. [ABSTRACT FROM AUTHOR]